Myocarditis risk greater after SARS-CoV-2 infection than after first dose of COVID-19 vaccine

Among nearly 43 million people in England, ages 13 and older, who received at least one dose and up to 3 doses of a COVID-19 vaccine, fewer than 3,000 people (0.007%) were hospitalized or died with myocarditis, or inflammation of the heart muscle, during the study period of December 1, 2020 through December 15, 2021.

Related Keywords

United States ,Nuffield ,Oxfordshire ,United Kingdom ,Edinburgh ,City Of ,American ,British ,Johnson Janssen ,Carolac Coupland ,Peter Watkinson ,Kamlesh Khunti ,Emily Henderson ,Julia Hippisley Cox ,Sharon Dixon ,Francesco Zaccardi ,Xuew Mei ,Lahiru Handunnetthi ,Keithm Channon ,Aziz Sheikh ,Martina Patone ,American Heart Association ,Us Centers For Disease ,Butler British Heart Foundation ,University Of Oxford ,Research Response Fund ,University Of Edinburgh ,Nuffield Department Of Primary Health Care Sciences ,Uk National Health Service ,Pfizer ,England National Immunization ,Astrazeneca ,Kingdom Research ,Disease Control ,Nuffield Department ,Primary Health Care Sciences ,National Immunization ,Professor Nicholas Mills ,Butler British Heart Foundation Chair ,Health Service ,Manu Shankar Hari ,Anthony Harden ,United Kingdom Research ,Covid 19 ,Myocarditis ,Vaccine ,Adenovirus ,Children ,Heart ,Immunization ,Inflammation ,Muscle ,Pandemic ,Mh ,Public Health ,Research ,